Has the gap between pancreas and islet transplantation closed?

Transplantation

Volumn 98, Issue 6, 2014, Pages 593-599

  Niclauss, Nadja ^a   Morel, Philippe ^a   Berney, Thierry ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Gap; Insulin independence; Islet transplantation; Pancreas transplantation; Type 1 diabetes

Indexed keywords

INSULIN;

FUNCTIONAL ASSESSMENT; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MEDICAL RESEARCH; MORBIDITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; TREATMENT INDICATION; TREATMENT RESPONSE; CHEMISTRY; CYTOLOGY; DIABETES MELLITUS, TYPE 1; ECONOMICS; HEALTH CARE COST; HYPOGLYCEMIA; PANCREAS; PATHOPHYSIOLOGY; PROCEDURES; REGISTER; RISK; SURGERY; TRANSPLANTATION; TREATMENT OUTCOME; UTILIZATION;

DIABETES MELLITUS, TYPE 1; HEALTH CARE COSTS; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS; PANCREAS TRANSPLANTATION; REGISTRIES; RISK; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 84922481083     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000288     Document Type: Review

References (56)

1. Patterson CC, Dahlquist GG, Gyürüs E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989Y2003 and predicted new cases 2005Y20: a multicentre prospective registration study. Lancet 2009; 373: 2027.
2. Imperatore G, Boyle JP, Thompson TJ, et al., SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the U.S. population aged G20 years through 2050. Diabetes Care 2012; 35: 2515.
3. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 293.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977.
5. Peyser T, Dassau E, Breton M, et al. The artificial pancreas: current status and future prospects in the management of diabetes. Ann N Y Acad Sci 2014; 1311: 102.
6. Vantyghem MC, Marcelli-Tourvieille S, Fermon C, et al. Intraperitoneal insulin infusion versus islet transplantation: comparative study in patients with type 1 diabetes. Transplantation 2009; 87: 66.
7. Gruessner AC. 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud 2011; 8: 6.
8. Boggi U, Vistoli F, Amorese G, et al. Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients. Transplantation 2012; 93: 842.
9. Alejandro R, Barton FB, Hering BJ, et al. 2008 update from the collaborative islet transplant registry. Transplantation 2008; 86: 1783.
10. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
11. Gremizzi C, Vergani A, Paloschi V, et al. Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 2010; 15: 119.
12. Fiorina P, Folli F, Bertuzzi F, et al. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 2003; 26: 1129.
13. Warnock GL, Thompson DM, Meloche RM, et al. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation 2008; 86: 1762.
14. Mohan P, Safi K, Little DM, et al. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 2003; 90: 1137.
15. Fiorina P, Venturini M, Folli F, et al. Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation. Diabetes Care 2005; 28: 1303.
16. Israni AK, Feldman HI, Propert KJ, et al. Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival. Am J Transplant 2005; 5: 374.
17. Vardanyan M, Parkin E, Gruessner C, et al. Pancreas vs. islet transplantation: a call on the future. Curr Opin Organ Transplant 2010; 15: 124.
18. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999Y2010. Diabetes Care 2012; 35: 1436.
19. Bellin MD, Barton FB, Heitman A, et al. Potent induction immunosuppression promotes long-term insulin independence after islet transplantation after type 1 diabetes. Am J Transplant 2012; 12: 1576.
20. Gruessner AC, Sutherland DER, Gruessner RWG. Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant 2012; 17: 100.
21. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
22. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
23. Harlan DM, Kenyon NS, Korsgren O, et al. Current advances and travails in islet transplantation. Diabetes 2009; 58: 2175.
24. Koh A, Senior P, Salam A, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplantation success. Transplantation 2010; 89: 465.
25. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004; 4: 390.
26. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
27. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008; 8: 2463.
28. Ryan EA, Paty BW, Senior PA, et al. Beta-score: an assessment of betacell function after islet transplantation. Diabetes Care 2005; 28: 343.
29. Vantyghem MC, Kerr-Conte J, Arnalsteen L, et al. Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes Care 2009; 32: 1473.
30. Borot S, Niclauss N, Wojtusciszyn A, et al. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network. Transplantation 2011; 92: 1031.
31. Shapiro AMJ, Toso C, Koh A, et al. Alemtuzumab induction and Tac/ MMF maintenance substantially improves long term insulin independence rates after clinical islet transplantation, and strongly suppresses both auto and alloreactivity. Transplantation 2010; 90S: 134.
32. Posselt AM, Szot GL, Frassetto LA, et al. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation 2010; 90: 1595.
33. Turgeon NA, Avila JG, Cano JA, et al. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant 2010; 10: 2082.
34. Gruessner RW, Gruessner AC. Pancreas transplant alone: a procedure coming of age. Diabetes Care 2013; 36: 2440.
35. Seventh CITR Annual Report. 2010, available at www.citregistry.org.
36. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955.
37. Fiorina P, Shapiro AM, Ricordi C, et al. The clinical impact of islet transplantation. Am J Transplant 2008; 8: 1990.
38. Wullstein C, Drognitz O, Woeste G, et al. High levels of C-reactive protein after simultaneous pancreas-kidney transplantation predict pancreas graft-related complications and graft survival. Transplantation 2004; 77: 60.
39. Scheffert JL, Taber DJ, Pilch NA, et al. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation 2013; 97: 681.
40. SteurerW, Malaise J, MarkW, et al. Euro-SPK Study Group. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols. Nephrol Dial Transplant 2005; 20: ii54.
41. Page M, Rimmelé T, Ber CE, et al. Early relaparotomy after simultaneous pancreas-kidney transplantation. Transplantation 2012; 94: 159.
42. Manrique A, Jiménez C, López RM, et al. Relaparotomy after pancreas transplantation: causes and outcomes. Transplant Proc 2009; 4: 2472.
43. Kempf MC, Andres A, Morel P, et al. Logistics and transplant coordination activity in the GRAGIL Swiss-French multicenter network of islet transplantation. Transplantation 2005; 79: 1200.
44. Wiseman AC,Wainright JL, Sleeman E, et al. An analysis of the lack of donor pancreas utilization from younger adult organ donors. Transplantation 2010; 90: 475.
45. Berney T, Johnson PR. Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation. Transplantation 2010; 90: 238.
46. Stegall MD, Dean PG, Sung R, et al. The rationale for the new deceased donor pancreas allocation schema. Transplantation 2007; 83: 1156.
47. Niclauss N, Bosco D, Morel P, et al. Influence of donor age on islet isolation and transplantation outcome. Transplantation 2012; 93: 703.
48. Deng S, Vatamaniuk M, Huang X, et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 2004; 53: 624.
49. Matsumoto I, Sawada T, Nakano M, et al. Improvement in islet yield from obese donors for human islet transplants. Transplantation 2004; 78: 880.
50. Hudson AJ, Fuggle SV, Friend PJ, et al. The UK national pancreas allocation scheme. Rev Diabet Stud 2011; 8: 144.
51. Badet L, Benhamou PY, Wojtusciszyn A, et al.; Group GRAGIL. Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial. Transplantation 2007; 84: 89.
52. Bucher P, Mathe Z, Bosco D, et al. Morbidity associated with intraportal islet transplantation. Transplant Proc 2004; 36: 1119.
53. Gruessner RWG, Sutherland DER, Gruessner A. Mortality assessment for pancreas transplants. Am J Transplant 2004; 4: 2018.
54. Douzdjian V, Escobar F, Kupin WL, et al. Cost-utility analysis of livingdonor kidney transplantation followed by pancreas transplantation versus simultaneous pancreas-kidney transplantation. Clin Transplant 1999; 13: 51.
55. Stratta RJ. The economics of pancreas transplantation. In: Hakim N, Stratta RJ, Gray D, eds. Pancreas and islet transplantation. New York: Oxford University Press; 2002: 277.
56. Guignard AP, Oberholzer J, Benhamou PY, et al. Cost analysis of human islet transplantation for the treatment of type 1 diabetes in the Swiss-French consortium GRAGIL. Diabetes Care 2004; 27: 895.